[ESPR] QoQ Quarter Result on 31-Dec-2018 [#Q4]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
28-Feb-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- -20.29%
YoY- -58.45%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Revenue 981 982 145,419 184,474 0 0 0 -
PBT -68,377 -54,221 87,379 -60,039 -49,911 -45,730 -46,130 29.97%
Tax 5,383 0 0 -74 0 0 0 -
NP -68,377 -54,221 87,379 -60,039 -49,911 -45,730 -46,130 29.97%
Tax Rate - - 0.00% - - - - -
Total Cost 69,358 55,203 58,040 244,513 49,911 45,730 46,130 31.21%
Ratio Analysis
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
NP Margin -6,970.13 -5,521.49 60.09 -32.55 0.00 0.00 0.00 -
Per Share
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
EPS -2.52 -2.01 3.26 -2.24 -1.86 -1.71 -1.73 28.47%
EPS Diluted -2.52 -2.01 3.07 -2.24 -1.86 -1.71 -1.73 28.47%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.